Shield Therapeutics PLC (LSE:STX) - Share price - Overview

Stock Report

Shield Therapeutics PLC STX

Last Price
GBX16.50

Day Change
0.00|0.00%

As of 23/04/2018
15:27:51 BST | GBX
Minimum 15 Minutes Delay.

Last Close16.50p
Day Range16.00 - 16.40
Mkt Cap19.21Mil
52-Wk Range14.00 - 168.00
Yield %-
ISINGB00BYV81293
Volume50,195
P/E-1.30
P/S0.55
P/CF-0.02

Share Price

Total Returns 20/04/2018

 Chg (%)  
More ...
Shield Therapeutics PLC-5.71 
FTSE 100 TR GBP7.27
 
Financials
201420152016
More ...
Income Statement
Turnover-0.000.30
Operating Profit-3.39-6.43-12.46
Net Profit-13.43-24.49-15.02
Reported EPS-12.00-22.00-15.00
Balance Sheet
Current Assets0.562.3323.38
Non Current Assets0.450.5329.00
Total Assets1.002.8652.38
Current Liabilities9.003.583.99
Total Liabilities19.2921.503.99
Total Equity-18.28-18.6448.40
Cash Flow
Operating Cash Flow-3.34-4.18-10.26
Net Change in Cash-1.070.2520.25
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/10/2017Exercise of OptionMr. Carl Andrew Sterritt100.008,8148,814.00
05/07/2017PurchaseDr. Andrew John William Heath150.003,3345,001.00
28/06/2017PurchaseJoanne Elizabeth Estell150.0020,00030,000.00
28/06/2017PurchaseMr. Peter Hermann William Llewellyn-Davies150.0010,00015,000.00

Company Profile

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

Sector

Drug Manufacturers - Specialty & Generic

Index

Next Event 27/04/2018

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-32.24
Op Mrgn-40.99
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Carl Andrew Sterritt
Non-Executive DirectorMr. Peter Hermann William Llewellyn-Davies
Non-Executive Director, ChairmanDr. Andrew John William Heath
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.